Companies / Callan JMB Inc
Callan JMB Inc
Nasdaq: CJMBCIK 2032545SPRING BRANCH, TX
Financials · FY2025
Ownership
5.6M shares outstanding · as of May 14, 2026
Ownership
| Insiders | 14.20% | 802,000 |
| 10%+ / strategic | 4.35% | 245,682 |
| Institutions | 8.19% | 462,527 |
| Public float | 73.25% | 4,135,909 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 2
View all →| Insider | % of shares | Shares |
|---|---|---|
Croyle David JChief Medical Officer · 10% owner | 14.17% | 800,000 |
Dial GeraldDirector | 0.04% | 2,000 |
Institutional holders 12
View all →| Holder | Value | % of shares |
|---|---|---|
| $306.9K | 4.35% | |
| $228.3K | 3.64% | |
| $145.3K | 2.32% | |
| $48.8K | 0.78% | |
| $28.7K | 0.41% | |
| $23.4K | 0.37% | |
| $13.9K | 0.22% | |
| $12.7K | 0.20% | |
| $11.4K | 0.18% | |
| $4.1K | 0.06% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Croyle David J Executive | Buy | Common Stock | $26.1K | +15K +1.91% | 789,805 13.99% of shares | low |
| Mar 20, 2026 | Croyle David J Executive | Buy | Common Stock | $17.8K | +10K +1.29% | 800,000 14.17% of shares | low |
| Dec 30, 2025 | Dial Gerald Director | Buy | Common Stock | $1.8K | +2K +333.84% | 2,000 0.04% of shares | low |
| Dec 30, 2025 | Dial Gerald Director | Buy | Common Stock | $562 | +461 | 461 <0.01% of shares | low |
| Feb 4, 2025 | Dial Gerald Director | Grant | Option (Right to Buy) | — | +25K | 25,000 0.44% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Bard Associates, Inc. | Passive13G/A | — |
| Bard Associates, Inc. | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| CJMB | — | 131100109 |